High‐dose proton pump inhibitor treatment is associated with a higher mortality in cirrhotic patients: a multicentre study
JS Yoon, JH Hong, SY Park, SU Kim… - Alimentary …, 2024 - Wiley Online Library
Background Proton pump inhibitors (PPI) are frequently used in patients with cirrhosis. Aims
This study aimed to determine whether PPI use is associated with the prognosis of cirrhotic …
This study aimed to determine whether PPI use is associated with the prognosis of cirrhotic …
Risks of Proton Pump Inhibitors in Patients with Cirrhosis: Please Peruse the Indications
EXS Low, YP Wang, CL Lu - Digestive Diseases and Sciences, 2024 - Springer
The use of proton pump inhibitor (PPI) in cirrhotic patients can be associated with increased
risks of long-term mortality, decompensation, hepatic encephalopathy, spontaneous …
risks of long-term mortality, decompensation, hepatic encephalopathy, spontaneous …
[引用][C] Risks of proton pump inhibitor treatment in cirrhotic patients
J Wang, F Wen, J Zhao - Alimentary Pharmacology & …, 2024 - Wiley Online Library
Letter: risks of proton pump inhibitor treatment in cirrhotic patients Page 1 1634 |
wileyonlinelibrary.com/journal/apt Aliment Pharmacol Ther. 2024;59:1634–1635. © 2024 John …
wileyonlinelibrary.com/journal/apt Aliment Pharmacol Ther. 2024;59:1634–1635. © 2024 John …